Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
To establish the bioequivalence of fixed dose combination of 40 mg telmisartan / 12.5 mg HCTZ vs. its monocomponents
Epistemonikos ID: 22cd551a6bca4e7b0b7d95fe8392cf0fffd4449a
First added on: May 12, 2024